Analysts See $-0.03 EPS for BioLife Solutions, Inc. (BLFS); LMP Capital & Income Fund (SCD) Sentiment Is 1.75

April 30, 2018 - By Peter Erickson

BioLife Solutions, Inc. (NASDAQ:BLFS) Logo

LMP Capital & Income Fund Inc (SCD) investors sentiment increased to 1.75 in Q4 2017. It’s up 1.12, from 0.63 in 2017Q3. The ratio improved, as 21 investment professionals increased and started new positions, while 12 reduced and sold stock positions in LMP Capital & Income Fund Inc. The investment professionals in our database now have: 4.59 million shares, down from 4.67 million shares in 2017Q3. Also, the number of investment professionals holding LMP Capital & Income Fund Inc in top ten positions was flat from 0 to 0 for the same number . Sold All: 4 Reduced: 8 Increased: 12 New Position: 9.

Analysts expect BioLife Solutions, Inc. (NASDAQ:BLFS) to report $-0.03 EPS on May, 10.They anticipate $0.04 EPS change or 57.14% from last quarter’s $-0.07 EPS. After having $-0.05 EPS previously, BioLife Solutions, Inc.’s analysts see -40.00% EPS growth. The stock increased 0.55% or $0.04 during the last trading session, reaching $7.26. About 15,320 shares traded. BioLife Solutions, Inc. (NASDAQ:BLFS) has risen 143.54% since April 30, 2017 and is uptrending. It has outperformed by 131.99% the S&P500.

Shaker Financial Services Llc holds 0.63% of its portfolio in LMP Capital and Income Fund Inc. for 95,217 shares. Cue Financial Group Inc. owns 37,883 shares or 0.35% of their US portfolio. Moreover, Cornerstone Advisors Inc has 0.26% invested in the company for 162,215 shares. The Colorado-based Advisors Asset Management Inc. has invested 0.1% in the stock. Rivernorth Capital Management Llc, a Illinois-based fund reported 89,235 shares.

The stock increased 0.23% or $0.03 during the last trading session, reaching $12.84. About 10,351 shares traded. LMP Capital and Income Fund Inc. (SCD) has declined 9.85% since April 30, 2017 and is downtrending. It has underperformed by 21.40% the S&P500.

Since January 1, 0001, it had 0 buys, and 2 sales for $125,101 activity.

LMP Capital and Income Fund Inc. is a closed ended balanced mutual fund launched and managed by Legg Mason Partners Fund Advisor, LLC. The company has market cap of $230.91 million. It is co-managed by Clearbridge Investments, LLC, Western Asset Management Company Limited, and Western Asset Management Company. It has a 7.43 P/E ratio. The fund invests in public equity and fixed income markets across the globe.

Among 3 analysts covering BioLife Solutions (NASDAQ:BLFS), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. BioLife Solutions had 7 analyst reports since June 14, 2017 according to SRatingsIntel. The firm earned “Buy” rating on Friday, November 10 by Maxim Group. As per Monday, July 31, the company rating was maintained by Maxim Group. The stock of BioLife Solutions, Inc. (NASDAQ:BLFS) has “Buy” rating given on Monday, March 12 by Northland Capital. The stock of BioLife Solutions, Inc. (NASDAQ:BLFS) earned “Buy” rating by Maxim Group on Friday, August 11. Maxim Group maintained the shares of BLFS in report on Wednesday, June 14 with “Buy” rating. Maxim Group upgraded the shares of BLFS in report on Thursday, November 30 to “Buy” rating. The stock of BioLife Solutions, Inc. (NASDAQ:BLFS) earned “Buy” rating by Janney Capital on Wednesday, July 5.

Investors sentiment decreased to 2.83 in 2017 Q4. Its down 5.17, from 8 in 2017Q3. It is negative, as 2 investors sold BioLife Solutions, Inc. shares while 4 reduced holdings. 8 funds opened positions while 9 raised stakes. 1.37 million shares or 30.77% less from 1.98 million shares in 2017Q3 were reported. Thompson Davis has 0.06% invested in BioLife Solutions, Inc. (NASDAQ:BLFS) for 4,000 shares. Salem Inv Counselors holds 0% or 72 shares in its portfolio. Morgan Stanley reported 215 shares. Blackrock accumulated 37,232 shares. Granite Inv Ltd Company holds 211,030 shares or 0.08% of its portfolio. First Manhattan has invested 0% of its portfolio in BioLife Solutions, Inc. (NASDAQ:BLFS). Tower Cap Limited Liability Corp (Trc) owns 439 shares. Perkins Mngmt reported 11,000 shares stake. Vanguard Grp Inc Incorporated reported 251,835 shares. Millennium Management Ltd Llc reported 182,550 shares. Geode Management Ltd Liability Com holds 69,384 shares or 0% of its portfolio. Renaissance Technologies Limited Liability Corp accumulated 37,599 shares. Hudock Capital Group Lc reported 0% in BioLife Solutions, Inc. (NASDAQ:BLFS). Wells Fargo And Com Mn owns 18,513 shares. Janney Montgomery Scott Ltd Co invested in 0% or 20,500 shares.

Since January 16, 2018, it had 0 insider buys, and 5 insider sales for $5.68 million activity. Rice Michael also sold $90,074 worth of BioLife Solutions, Inc. (NASDAQ:BLFS) shares. The insider GIRSCHWEILER THOMAS sold $5.39M.

BioLife Solutions, Inc. develops, manufactures, and markets patented hypothermic storage and cryopreservation solutions for cells and tissues in the United States. The company has market cap of $102.70 million. The Company’s products are serum-free and protein-free solutions, which are formulated to reduce preservation-induced, delayed-onset cell damage, and death. It currently has negative earnings. The firm offers HypoThermosol FRS, a hypothermic storage and shipping media product to mitigate temperature-induced molecular cell stress responses that occur during chilling and re-warming of biologics, intermediate products, and final cell products intended for research and clinical applications; and CryoStor cryopreservation freeze media products, which are designed to mitigate temperature-induced molecular cell stress responses during freezing and thawing.

BioLife Solutions, Inc. (NASDAQ:BLFS) Ratings Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>